Pediatric Oncology Patients' Artwork - Gallery 2

Ultima Vez Modificado: 1 de noviembre del 2001

Share article


Imprima English


By: David, Age 11


By: Jason, Age 10


By: Megan, Age 8


By: Olivia, Age 14


By: Sarah, Age 8


By: Jackie, Age 10


By: Lauren, Age 11

 

By: Kenya, Age 12


By: Michelle, Age 5


By: Jason, Age 10


By: Jason, Age 14


By: Jason, Age 14


By: Jason, Age 14

Imprima English
News
Lexatumumab Tolerated for Pediatric Solid Tumors

Oct 17, 2012 - Lexatumumab, an agonistic, full human monoclonal antibody against tumor necrosis factor-related apoptosis-inducing ligand receptor 2, is well tolerated and may lessen certain clinical symptoms in some pediatric patients with solid tumors, according to a study published online Oct. 15 in the Journal of Clinical Oncology.



Blogs and Web Chats

OncoLink Blogs give our readers a chance to react to and comment on key cancer news topics and provides a forum for OncoLink Experts and readers to share opinions and learn from each other.




OncoLink OncoPilot

Frente a un nuevo diagnóstico de cáncer o de cambiar el curso de su tratamiento actual? Deje que nuestro personal de enfermería cáncer que ayudan a pasar!

Más información